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Detection and prevalence of depression 
among adult type 2 diabetes mellitus patients 
attending non-communicable diseases clinics 
in Lilongwe, Malawi
Michael Udedi1,2,3* , Brian W. Pence5, Robert C. Stewart1,6,7 and Adamson S. Muula3,4
Abstract 
Background: Depression is associated with chronic physical illnesses and negatively affects health outcomes. 
However, it often goes undiagnosed and untreated. We investigated the prevalence of depression among adult 
type 2 diabetes mellitus (T2DM) patients attending non-communicable diseases (NCD) clinics in Lilongwe, Malawi, 
and estimated the level of routine detection by NCD clinicians. This study set out to determine the prevalence of 
major depression and its detection among adult type 2 diabetes mellitus (T2DM) patients attending NCD clinics in 
Lilongwe, Malawi.
Methods: In a cross-sectional study design, 323 T2DM patients aged ≥ 18 years were screened for depression with 
the Patient Health Questionnare-9 (PHQ-9) followed by diagnostic assessment with the Structured Clinical Interview 
for DSM-IV (SCID). We analysed the association between presence of major depression and sociodemographic factors 
using logistic regression.
Results: Three quarters of the participants (76%) were females. The participants’ ages ranged from 21–79 years. Of 
the 323 participants, 58 (18%) met criteria for DSM-IV major depression. None of the cases of major depression had 
been identified by the NCD clinicians. Major depression was found not to be significantly associated with any of the 
sociodemographic factors.
Conclusions: We found that depression is common among NCD clinic attendees with T2DM in Malawi, and poorly 
detected by NCD clinicians. Given the high prevalence and challenges in clinical identification, integration of depres-
sion screening with a standardized validated tool should be a high priority so as to link patients to appropriate 
services.
Keywords: Depression, Type 2 diabetes mellitus, Malawi
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds 
the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://crea-
tivecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdo-
main/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Introduction
Depression is associated with chronic physical ill-
nesses and negatively affects health outcomes [1, 2]. 
Few affected people access appropriate treatment as 
depression is often undiagnosed. Diabetes mellitus is 
a common chronic disease, and in Malawi, the preva-
lence of raised fasting blood glucose or being currently 
on medication for diabetes based on the 2009 STEPS 
survey was 5.6% [3]. A systematic review shows that the 
prevalence of depression in patients with diabetes mel-
litus ranges between 6 and 43% [4]. The wide range of 
reported prevalence estimates may be due to differences 
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in the studies cohorts. Depression in patients with dia-
betes is often associated with poor glycaemic control, 
poor adherence to medication, and rapid development 
of complications [5–7]. For instance a diabetic compli-
cation such as diabetic neuropathy is associated with 
reduced quality of life, poor sleep, depression and anxiety 
[8].  Comorbid depression is associated with a decrease 
in metabolic control, poor adherence to medication 
and diet regimens, a reduction in quality of life, and an 
increase in health care expenditures. Consequently, poor 
metabolic control may exacerbate depression and dimin-
ish response to depression treatment [9]. Evidence indi-
cates that depression complicate diabetes management, 
increase the length of hospital stays, and almost doubled 
the cost of diabetes management [10]. Literature also 
suggests that duration of diabetes influences depressive 
symptoms [11]. Furthermore, depression is often undiag-
nosed and untreated in this patient population [12–16]. 
Despite the high prevalence and its impact on diabetes, 
the potential for depression treatment to improve diabe-
tes care outcomes has received little attention in both low 
and middle income countries (LMIC) [17–19], and high 
income countries. In LMIC this lack of attention is partly 
because of limited capacity in depression management 
and the absence of any routine practice to identify and 
manage depression in NCD care.
Malawi is facing a growing challenge of non-com-
municable diseases (NCD), including diabetes mellitus 
[20–23]. Furthermore, Malawi has a large treatment gap 
for common mental disorders including depression with 
a limited number of mental health professionals serv-
ing a population of > 18 million. Prevalence of depres-
sion between 19 and 30% has been reported among adult 
primary care attendees in Malawi [24, 25]; none of these 
cases of depression were identified by clinicians in rou-
tine care [24, 25]. There are no published data regarding 
the prevalence of depression among patients with dia-
betes attending NCD clinics, or of levels of detection by 
clinic staff. Currently, there is no routine screening for 
depression in the NCD clinics in the country.
Therefore, the aim of this study was to determine the 
prevalence of major depression and its detection by cli-
nicians among adult type 2 diabetes mellitus (T2DM) 
patients attending NCD clinics in Lilongwe, Malawi.
Materials and methods
Setting and participants
We carried out a cross-sectional study from Decem-
ber 2017 till April 2018 among patients suffering from 
diabetes mellitus. We conducted the study at two dia-
betes clinics in two facilities within Lilongwe district. 
The catchment population of the two clinics and the 
staffing levels have been described elsewhere [26]. 
The patients attending to the clinics are not routinely 
screened for any mental health problems. We included 
adult patients with T2DM who provided consent to 
participate in the study. The exclusion criteria included 
patients with Type 1 diabetes mellitus, patients who 
were too ill, and those suffering from an illness causing 
inability to communicate.
Data collection
We collected data from consecutive adult participants 
with T2DM attending the diabetes clinic at the two 
facilities. We chose a consecutive sampling technique 
because it includes all patients who are accessible 
within the defined study time period [27]. Participants 
were recruited after they had seen an NCD clinician 
for routine care. Participants provided written consent 
after which socio-demographic data was collected and 
were then screened using the Patient Health Ques-
tionnaire-9 (PHQ-9) [28] by a research assistant. The 
PHQ-9 is a 9-item screening tool which is widely used 
in clinical practice and research. The PHQ-9 Chichewa 
version has been validated in Malawi and described 
elsewhere [29]. All participants who underwent PHQ-9 
screening were requested to meet the Structured Clini-
cal Interview for DSM-IV (SCID) [30] interviewer after 
their clinical consultation. The participants later com-
pleted the diagnostic interview administered by the 
SCID interviewer who was masked from the PHQ-9 
scores of the participants. The SCID was used to make 
a diagnosis of depression among the patients.
The clinicians working at the two facilities’ NCD 
clinics were all clinical officers (COs). Clinical officers 
are para-medicals who are trained to provide general 
medico-surgical care; they are trained for four years 
consisting of 3  years’ college education followed by a 
year of internship [31–34]. The clinicians in this study 
had basic mental health training as part of their clini-
cal officer’s training and were not given any extra train-
ing for this study. The clinicians reviewed the patients 
and made entries in the patient’s medical booklet (com-
monly known as a health passport [35]) as well as NCD 
master-cards (chronic care medical charts which are 
kept at the clinic). They recorded the presenting com-
plaint, history of the presenting illness, any pertinent 
past history, findings of the physical examination, diag-
nosis, any investigations requested and treatment pro-
vided. To assess whether depression had been detected 
as part of routine clinical care, data on the consultation 
written by the clinician was extracted from the health 
passports, to ascertain whether a diagnosis of depres-
sion was made or not during the clinical encounter.
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Data analysis
For screening data obtained using the PHQ-9, the pres-
ence of depressive symptoms was defined as having a 
total score of at least 5 (PHQ-9 total score ≥ 5). PHQ-9 
total scores were categorised as follows: [36, 37].
• 0–4No or minimal depressive symptoms
• 5–9Mild depressive symptoms
• 10–19Moderate depressive symptoms
• 20–27Severe depressive symptoms
DSM IV diagnoses obtained using the SCID were: 
no depression, minor depression and major depres-
sion. Sociodemographic factors measured were: age, 
sex, education, employment status and marital status. 
We analysed the association between presence of major 
depression and sociodemographic factors using logis-
tic regression. Statistical analysis was carried out using 
both SPSS version 20.0 and Stata 14.
Ethical approval
The University of Malawi College of Medicine Research 
and Ethics Committee (COMREC) approved the study 
protocol. We obtained written informed consent from 
every participant and fingerprint impressions were 
taken from consenting participants who could not 
write. Privacy was maintained during the interviews 
with participants at the health facilities as the inter-
views were conducted in a room which provided both 
visual and audio privacy.
Results
Demographic data
Our study included all 323 participants with type 2 dia-
betes mellitus who were approached, consented and 
completed the questionnaires (PHQ-9 and SCID); there 
were no refusals. 244 (76%) were female. Participants’ 
ages ranged from 21–79  years with a mean (standard 
deviation) of 54.0 (11.4). 8.4% of the participants were 
illiterate. Table 1 shows patients’ characteristics.
Severity score of depressive symptoms and prevalence 
of probable depression based on PHQ‑9
The distribution of severity of depressive symptoms 
based on the PHQ-9 scores is shown in Table 2.
Prevalence of depression based on SCID
The prevalence of DSM IV depression diagnoses based 
on the SCID were: no depression 58.2% (n = 190), 
minor depression 23.8% (n = 75) and major depression 
18% (n = 58).
Distribution by major depression status 
and socio‑demographic characteristics based on multiple 
logistic regression analyses
Major depression was found not to be significantly 
associated with any of the sociodemographic variables: 
education level (p < 0.07) age, gender (p < 0.47), marital 
status (p < 0.92), and current employment status (p < 0.34) 
(Table 3).
Table 1 Socio-demographic characteristics of  study 
participants




 21–30 10 3.1
 31–40 33 10.2
 41–50 75 23.2
 51–60 106 32.8
 61–70 85 26.3
 71–80 14 4.3
Education
 No education 27 8.4
 Primary 153 47.4
 Secondary/tertiary 143 44.3
Employment status
 Employed 143 44.3
 Unemployed 180 55.7
Gender
 Male 79 24.5
 Female 244 75.5
Marital status
 Married 249 77.1
 Unmarried 74 22.9
Table 2 Severity score of  depressive symptoms based 
on PHQ-9




No or minimal depressive 
symptoms
0–4 132 40.9




Severe depressive symptoms 20–27 7 2.2
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Detection of depression by NCD Clinicians
None of the participants were diagnosed as having 
depression during routine clinical assessment by the 
NCD clinicians. This included the 58 participants who 
were identified as having major or minor depression 
using SCID.
Discussion
Recognising a mental disorder such as depression in 
patients with physical illness is important in clinical man-
agement and improving patients’ clinical outcomes. In 
this population of adult type 2 diabetes mellitus (T2DM) 
patients attending non communicable diseases (NCD) 
clinics in Lilongwe, Malawi, we investigated the preva-
lence and rate of routine detection of depression, finding 
that 18% of participants met criteria for major depres-
sion, none of whom were detected in routine practice by 
the NCD clinicians.
Prevalence of depression among people with T2DM
Evidence indicate that 18%–25% of people with T2DM 
will meet DSM criteria for a major depressive episode 
using the SCID [11]. The prevalence of major depres-
sion in T2DM in our study is comparable to prevalence 
estimates of 19% and 30% found in two studies of gen-
eral primary care outpatient attendees in Malawi [24, 
25]. There is some overlap with the populations in the 
previous studies as these were conducted in facilities 
that did not have dedicated NCD clinics, so will have 
included patients with T2DM. The finding of our study 
that one-fifth of patients with T2DM (18%) suffered from 
major depression is similar to the findings of a systematic 
review by Roy and Lloyd where the they found a preva-
lence of 19.1% (range 6.5–33%) [4] however the finding 
is considerably higher compared to that of a collaborative 
study carried out in 14 countries which found a preva-
lence of 10.6% [38]. The rate of major depression in this 
study is also comparable to rates of depression in stud-
ies from Nigeria with a prevalence of 19.4% based on the 
SCID [39] and from Ethiopia with a prevalence of 17% on 
the Beck Depression Inventory (BDI) [40].
In contrast to our study, several studies in other Afri-
can countries have shown higher prevalence of depres-
sion among T2DM patients. A study in Morocco found 
that patients with T2DM had higher prevalence of major 
depression (33.1%) [41] while studies in South Africa 
found and in Egypt found 46% and 32% respectively 
[39]. Similarly a systematic review conducted in Ethiopia 
showed that the prevalence of depression among T2DM 
patients was 39.73% [42]. In other LMICs the findings of 
higher prevalence of major depression are also similar. 
For instance a multi-centre study conducted in Pakistan 
Table 3 Prevalence of major depression by individual socio-demographic characteristics in adults with type 2 diabetes 
mellitus based on multiple logistic regression analyses
* Reference category
Variable No Depression Depression P‑value OR 95% CI
n % n %
Age (years)
 21–30* 9 90 1 10 1 (ref )
 31–40 26 78.8 7 21.2 0.442 2.414 0.255 22.88
 41–50 61 81.3 14 18.7 0.617 1.744 0.191 15.42
 51–60 87 82.1 19 17.9 0.667 1.604 0.187 13.75
 61–70 71 83.5 14 16.5 0.762 1.396 0.167 12.14
 71–80 11 78.6 3 21.4 0.624 1.849 0.158 21.63
Education
 No education* 19 70.4 8 29.6 1 (ref )
 Formal education 246 83.1 50 16.9 0.069 1.082 0.404 1.035
Employment status
 Employed* 122 85.3 21 14.7 1 (ref )
 Unemployed 143 79.4 37 20.6 0.340 1.082 0.920 1.272
Gender
 Male* 68 86.1 11 13.9 1 (ref )
 Female 197 80.7 47 19.3 0.466 1.315 0.629 2.746
Marital status
 Married* 204 81.9 45 18.1 1 (ref )
 Unmarried 61 82.4 13 17.6 0.922 0.966 0.481 1.937
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found that 43.5% of T2DM patients had depression 
[43]. A Mexican study also found a higher prevalence of 
48.27% [44] compared to our study.
Depression screening and diagnosis
Depression is diagnosed using a structured clinical inter-
view, such as the SCID and other interviews such as 
Composite International Diagnostic Interview (CIDI). 
However the interviews vary in terms of length as such 
they can be time-consuming therefore depression can 
be screened accurately using a few questions such as the 
PHQ-9 [11]. A variety of screening tools for depression 
are available, however few have been developed for use in 
LMIC settings [45]. In our study, the majority of patients 
(34.4%) had mild depression, 22.6% had moderate and 
2.2% had severe depression based on PHQ-9 scores. Our 
finding is similar to findings in other LMICs, for instance 
a study in Iran that showed that 38% of patients had mild 
depression, 30% had moderate depression, and 13% had 
severe depression on the BDI [46]. Further, the findings 
are also similar to a study in Tanzania which showed 
that 22.1% had mild depression, and 8.2% had moderate 
depression while none had severe depression based on 
the PHQ-9 [6]. An Indian study also found almost simi-
lar finding which showed that 25% had mild depression, 
12.5% had moderate depression, and 1.3% had severe 
depression on the Major Depression Inventory (MDI) 
[7]. In contrast to our study, a Bangladesh study found 
that majority of patients (20.2%) had severe depression 
rather than mild to moderate depression (14.6%) using 
the Centre for Epidemiological Studies Depression Scale 
[47]. One of the reasons could be because of the relatively 
small size of the data sample in the Bangladesh study 
compared to our study and the other reason could be the 
use of different tools.
Interventions for comorbid depression and diabetes
Most low and middle income countries have a large 
treatment gap for common mental disorders including 
depression [48]. Studies suggest that one way of reducing 
the treatment gap is the integration of mental health into 
other health care services [49, 50]. Integrating depression 
screening and treatment into primary care to improve 
access to mental health services mostly in low- and mid-
dle-income countries (LMICs) is being advocated [51]. 
Furthermore, it has been suggested that mental health 
care and NCD care should be offered together in primary 
care platforms due to the growing burden of both [52]. 
There is evidence that demonstrates the effectiveness of 
a range of mental disorder interventions, including medi-
cines, psychological treatments, and social interventions 
delivered by non-mental health specialist in LMICs [53]. 
A systematic review of collaborative care for patients 
with comorbid conditions provides evidence to support 
the effectiveness of integrated care in improving depres-
sion outcomes and improved adherence to treatment for 
both depression and diabetes [54].
Despite the advocacy of the initiative, many barri-
ers to integration exist. For instance, a potential bar-
rier to integrating screening into routine practice and 
ensuring patients with depression receive the necessary 
required care is that many health workers in LMICs are 
not trained or do not have time to screen for depression 
when seeing patients [45].
Despite the high prevalence of depression, none of 
the patients who were diagnosed with major depres-
sion by the research team using the SCID were detected 
and diagnosed as such by the NCD clinician. This find-
ing agrees with other studies conducted among patients 
with T2DM [12–16]. The reasons for non-detection of 
depression in this setting could be due to lack of knowl-
edge and skills, lack of integration of mental health in 
NCD care and lack of routine screening for depression. 
These reasons are in line with the results from general 
primary care clinics studies in Malawi [24, 25]. The fail-
ure to detect and manage depression will affect manage-
ment of T2DM as evidenced in other studies [15, 16]. 
Several studies have demonstrated that depression treat-
ment effectively reduces the severity of depression in 
patients with diabetes and also produces better glycaemic 
control [55], significantly improve HbA1C [56] restore 
mental health and improve medical outcome [57]. As 
such if depression in patients with diabetes is not recog-
nized, it will go untreated and consequently the medical 
and mental health outcomes will be negatively affected. 
Detecting depression in the clinical setting is aided by 
validated tools that can be easily administered with lim-
ited resources. Improved detection of depression through 
the use of the PHQ-9 by the clinicians would lead to 
the initiation of treatment or referral to mental health 
services for treatment which may consequently lead to 
improved outcomes and lower complications. Therefore, 
NCD clinicians have to be equipped with the necessary 
knowledge and skills in detection and treatment.
Based on multivariable logistic regression, the soci-
odemographic factors including age, gender, education, 
marital status and employment were not associated with 
depression. Related studies have gotten varying results 
with many similarly finding no association with this set of 
factors [1, 17, 58–63]; but, some individual studies show-
ing associations with them [64–67]. In the present study, 
three quarters of the participants were females. However, 
it is unlikely that this had an influence on the results for 
females as there was no evidence of a difference in the 
odds of depression between the two genders. The over 
representation of females in our study is similar to other 
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studies like the Malawi STEPS Survey [68], which may 
be due to the increased health care seeking behaviour by 
females relative to males.
One notable strength of this study is that it used a gold 
standard, the SCID for depression that had previously 
been used in different studies in Malawi. Furthermore, 
the quality of administration of the PHQ-9 and of the 
SCID was very good as the research assistants had train-
ing in administration of the research tools and received 
regular supervision from the principal investigator. To 
our knowledge, this is the first study analyzing depression 
among patients with diabetes in Malawian population.
Study limitations
The results of this study should however be interpreted 
in light of limitation. The limitation of this study is that 
the participants were selected through a consecutive 
sampling technique from two specialized NCD clinics in 
Lilongwe which may not be representative of the wider 
population. However, despite this limitation, the paper 
fills an important knowledge gap regarding the preva-
lence and detection of depression among patients with 
diabetes in Malawi, given the dearth of evidence in LMIC 
settings. In this regard, the paper shows a crucial gap and 
has the potential to stimulate policy makers and clini-
cians to develop interventions to improve detection of 
depression among patients with diabetes.
Conclusions
Depression is prevalent among patients with type 2 dia-
betes mellitus attending NCD clinics in Malawi. The 
evidence from this study shows that depression is undiag-
nosed in patients with diabetes in NCD clinics. Clinicians 
in NCD clinics must know how to screen for depression 
and ensure availability of treatment. Clinicians should 
consider using screening tools to identify depression 
among patients with type 2 diabetes. Furthermore, there 
must be a parallel focus on establishing mental health 
services to which these identified patients could be con-
nected. It is therefore important to explore ways to iden-
tify depression in NCD clinics.
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